Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer
Current Oncology · 2023
DOI: 10.3390/curroncol30010086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Peiyu Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province, China.
Abstract (Originalsprache)
Gastric cancer is one of the most common gastrointestinal cancers. Early diagnosis can improve the 5-year survival rate. This study aimed to evaluate the cost-effectiveness of Helicobacter pylori (Hp) and a new gastric cancer screening scoring system (NGCS) in areas with a high incidence of gastric cancer. A decision-analytic Markov model was constructed based on the theory and method of cost-effectiveness analysis, which included three decisions: no screening, Hp screening, and NGCS screening. The uncertainty of each parameter in the model was determined using a one-way sensitivity analysis and probability sensitivity analysis. The results of the cost-effectiveness analysis revealed that the application of the NGCS had the highest cost-effectiveness, while the one-way sensitivity analysis revealed that the probability of intestinal metaplasia progression to dysplasia had the most significant effect on the incremental cost-effectiveness ratio. The probability sensitivity analysis concluded that the result of the NGCS having the highest cost-effectiveness was stable. Although the application of the NGCS will require upfront screening costs, it can significantly improve the detection rate of early gastric cancer and save the consequent long-term healthcare costs. It is practicable and can be popularized in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Shanxi Medical University, Taiyuan 030001, China.
- Department of Gastroenterology, The First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Förderung
- Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province, China
Zitieren
APA
Zheng, P., & Liu, J. (2023). Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer. Current Oncology. https://doi.org/10.3390/curroncol30010086
Vancouver
Zheng P, Liu J. Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer. Current Oncology. 2023. doi:10.3390/curroncol30010086
BibTeX
@article{Zheng2023,
author = {Zheng, Peiyu and Liu, Jinchun},
title = {Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30010086}
}
EUVIMED